PetVivo Holdings Inc (NASDAQ:PETV) — Market Cap & Net Worth
Market Cap & Net Worth: PetVivo Holdings Inc (PETV)
PetVivo Holdings Inc (NASDAQ:PETV) has a market capitalization of $35.24 Million ($35.24 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23271 globally and #5005 in its home market, demonstrating a -23.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PetVivo Holdings Inc's stock price $1.12 by its total outstanding shares 31573167 (31.57 Million). Review PetVivo Holdings Inc (PETV) total liabilities to assess the company's total debt and financial obligations.
PetVivo Holdings Inc Market Cap History: 2015 to 2025
PetVivo Holdings Inc's market capitalization history from 2015 to 2025. Data shows change from $371.86 Million to $35.24 Million (-23.19% CAGR).
PetVivo Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PetVivo Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
31.11x
PetVivo Holdings Inc's market cap is 31.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $56.12 Million | $75.00K | -$1.57 Million | 748.33x | N/A |
| 2017 | $235.75 Million | $7.12K | -$15.53 Million | 33092.44x | N/A |
| 2018 | $70.17 Million | $1.51K | -$2.34 Million | 46469.01x | N/A |
| 2019 | $61.63 Million | $77.94K | -$4.76 Million | 790.79x | N/A |
| 2020 | $418.34 Million | $3.59K | -$2.11 Million | 116595.45x | N/A |
| 2021 | $119.03 Million | $12.58K | -$3.75 Million | 9463.42x | N/A |
| 2022 | $61.88 Million | $115.59K | -$4.94 Million | 535.36x | N/A |
| 2023 | $33.47 Million | $917.16K | -$8.70 Million | 36.49x | N/A |
| 2024 | $16.26 Million | $968.71K | -$10.96 Million | 16.79x | N/A |
| 2025 | $35.24 Million | $1.13 Million | -$8.40 Million | 31.11x | N/A |
Competitor Companies of PETV by Market Capitalization
Companies near PetVivo Holdings Inc in the global market cap rankings as of June 18, 2026.
Key companies related to PetVivo Holdings Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $153.89 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #252 globally with a market cap of $100.32 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $153.89 Billion | $88.50 |
| #212 | Stryker Corporation | NYSE:SYK | $115.24 Billion | $301.14 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #252 | Medtronic PLC | NYSE:MDT | $100.32 Billion | $78.14 |
PetVivo Holdings Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, PetVivo Holdings Inc's market cap moved from $371.86 Million to $ 35.24 Million, with a yearly change of -23.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $35.24 Million | +116.70% |
| 2024 | $16.26 Million | -51.42% |
| 2023 | $33.47 Million | -45.92% |
| 2022 | $61.88 Million | -48.01% |
| 2021 | $119.03 Million | -71.55% |
| 2020 | $418.34 Million | +578.79% |
| 2019 | $61.63 Million | -12.17% |
| 2018 | $70.17 Million | -70.24% |
| 2017 | $235.75 Million | +320.05% |
| 2016 | $56.12 Million | -84.91% |
| 2015 | $371.86 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of PetVivo Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.24 Million USD |
| MoneyControl | $35.24 Million USD |
| MarketWatch | $35.24 Million USD |
| marketcap.company | $35.24 Million USD |
| Reuters | $35.24 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PetVivo Holdings Inc
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for … Read more